BCL6 and cancer: Indeed, from single cell RNA sequencing and flow cytometry data, we demonstrated that cancer cells with high expression of Bcl6 inhibit tumor immune cell infiltration, and suppress tumor-infiltrating CD4+T cells and CD8+T cells activity (Fig. 3).